Full-Time
Production Engineer
Updated on 8/10/2026
Alcon
10,001+ employees
Eye care products and vision solutions
No salary listed
Mulgrave, Australia
In Person
Full Australian work rights are required; no relocation support is provided.
Bachelor's
 Operations & Logistics (1) |
|---|
Get referred to Alcon
See people who can refer or advise you
- A degree in Engineering or a related technical discipline is required.
- Strong engineering fundamentals and logical, structured problem-solving skills are required.
- The candidate must be practical and hands-on, with confidence supporting manufacturing processes, troubleshooting, and engineering investigations in a production environment.
- The candidate must have strong communication and teamwork skills in a cross-functional environment.
- The candidate must have full Australian work rights; visa sponsorship and relocation support are not provided.
- Provide hands-on engineering support to day-to-day manufacturing operations.
- Work directly with technicians on the production floor to troubleshoot product, process, test, calibration, and equipment-related issues.
- Investigate manufacturing problems using logical, structured, and evidence-based problem-solving.
- Support root-cause investigations and drive issues through to effective resolution.
- Identify and support opportunities to improve quality, yield, efficiency, process stability, and production throughput.
- Participate in daily production meetings and communicate priorities, technical issues, risks, and required actions.
- Escalate issues impacting safety, quality, delivery, or production while supporting their resolution.
- Work collaboratively across Production, Engineering, Quality, New Product Introduction, Systems, and Research and Development teams.
- Support engineering trials, process changes, and continuous improvement activities.
- Prepare, update, and maintain production documentation, including work instructions, rework instructions, nonconformance reports, engineering change notices, and production records.
- Manufacturing, production, test, or similar hands-on engineering experience is preferred.
- Curiosity, proactivity, willingness to learn, and a strong sense of ownership are preferred.
Alcon provides eye care products and vision solutions to improve how people see. It develops and manufactures devices and consumables for eye health, including cataract surgery equipment and intraocular lenses, retinal health therapies, and contact lenses, distributed through eye care professionals, hospitals, and consumers. The products work by supporting eye surgery, protecting and restoring vision, or correcting vision with lens-based options, backed by research and development and a global distribution network. Alcon differentiates itself with a broad, end-to-end portfolio across the eye care continuum, a strong emphasis on research and development, strategic partnerships with healthcare providers, and a commitment to diversity and inclusion. Its goal is to enhance vision and quality of life by delivering reliable, high-quality eye care solutions and advancing the science of eye health.
Company Size
10,001+
Company Stage
IPO
Headquarters
Geneva, Switzerland
Founded
1945
Get referred to Alcon
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 sales rose 7% to $2.78 billion, beating estimates on August 11.
- Alcon lifted 2026 EPS growth guidance to 12%-15% and margin expansion to 90-190 bps.
- PanOptix Pro and UNITY CS launches, plus RxSight collaboration, extend growth through 2027.
What critics are saying
- August 2026 ShinyHunters breach exposed 218,395 records, damaging trust with providers and partners.
- Alcon booked a $402 million PowerVision charge on August 11, 2026, after failed IOL outcomes.
- Competitors keep launching cataract and adjustable-lens products, pressuring Alcon's IOL share into 2027.
What makes Alcon unique
- Alcon spans cataract, retina, and contact lenses across 140 countries, limiting concentration risk.
- PanOptix Pro and UNITY platforms defend premium ophthalmology workflows with surgeon adoption.
- Aravind partnership launched retina training centers in 2024 and 2026, deepening professional loyalty.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical, dental, & vision coverage
HSA Medical Plan
PTO
Paid Parental leave
401k
Retirement Plan Company Contribution
Low payroll deductions
Tuition Reimbursement Program
Annual Bonus
Free Family Contact Lens Program
12 Company Paid Holidays
Growth & Insights and Company News
6 month growth
↑ 11%1 year growth
↑ 11%2 year growth
↑ 11%Swiss stocks dip as Alcon jumps and UBS rules wait. The Swiss Market Index closed 0.40% lower as Alcon rose 4.70% on stronger guidance and lawmakers delayed a vote on UBS capital changes until Aug. 31. 38 minutes ago - 1 min What's going on here? Swiss stocks ended Tuesday slightly lower, but eye-care company Alcon popped 4.70% after raising its outlook and Swiss lawmakers pushed a vote on tougher UBS capital rules to Aug. 31st. What does this mean? The Swiss Market Index slipped 0.40% in a session short on local data, leaving company news to do most of the talking. Alcon said first-half sales rose 9% year-on-year to $5.47 billion and lifted guidance for core operating margin and core earnings per share, even after booking a $402 million pretax, non-cash charge from winding down its PowerVision programs. RBC, a Canadian bank, also noted Alcon cut its estimate of tariff damage to $40-90 million, helped... Keep reading for free. This content is free, but you must be logged in to continue reading. Already have an account?
Alcon reported Q2 revenues of approximately $2.8bn, marking an 8% year-over-year increase. The Swiss eyecare company raised its 2026 earnings growth outlook to 12–15% per diluted share, up from 10–13% previously, whilst maintaining its sales growth forecast at 5–7%. The surgical segment generated around $1.6bn in Q2, up 8% year-over-year, whilst vision care brought in approximately $1.2bn, also up 8%. Operating income fell to $11m from $247m last year after Alcon took a $402m pre-tax charge to discontinue intraocular lens programmes acquired from PowerVision in 2019, citing unacceptable patient outcomes. CEO David Endicott attributed the strong performance to recent product launches, including the PanOptix Pro trifocal IOL. Alcon's shares rose approximately 2% to $75.10 in pre-market trading.
Alcon has raised its full-year profit guidance and revised down its tariff impact estimate to $40 million to $90 million, from $100 million to $150 million previously, after anticipating a $60 million refund from the US government. The US represents 45% of the Swiss-American eye care company's net sales. The company now expects its core operating profit margin to rise 90 to 190 basis points in 2026, up from 70 to 170 basis points. Core diluted earnings per share growth guidance was also increased to 12% to 15%, from 10% to 13%. Second-quarter net sales rose to $2.78 billion from $2.58 billion year-on-year, beating analyst expectations. Adjusted earnings per share reached $0.84, surpassing the $0.75 estimate.
Alcon - 218,395 breached accounts. 2026-08-09 14:08 In August 2026, the Alcon eye care company was named in a ShinyHunters "pay or leak" extortion campaign. The group subsequently published data allegedly sourced from Alcon containing 218k unique email addresses along with other largely corporate B2B contact fields, including name, phone number and physical address. Read the original article: In June 2026, Inter-Con Security was targeted in a ShinyHunters "pay or leak" extortion campaign. The group subsequently published data it alleged was... Secure email service August 6, 2026 In June 2026, telecommunications tower infrastructure company American Tower was the target of a ShinyHunters "pay or leak" extortion campaign. The group subsequently published data allegedly taken from the company containing more than 200k unique email addresses belonging to employees, contractors, customers, and leads. Exposed data also included names, addresses,... June 26, 2026 In July 2026, electronic test and measurement equipment company Fluke was targeted in a ShinyHunters "pay or leak" extortion campaign. The group subsequently published more than 100GB of data allegedly taken from the company. The corpus contained largely corporate contact information, including over 800k unique email addresses, names, phone numbers... July 15, 2026
Ransomware Group shinyhunters hits: Alcon Inc. HookPhish team Target organization Alcon Inc. alcon.com Healthcare Summary. In the latest cybersecurity news, Alcon Inc. - an organization based in CH - has fallen victim to a ransomware attack conducted by the group shinyhunters. This data breach, discovered on Aug 2, 2026, 00:00 UTC, underscores the increasing need for proactive cybersecurity defenses as HookPhish continue through 2026. Incident report. | Target Organization | Alcon Inc. | | Threat Group | shinyhunters | | Summary | Over 25 million Salesforce records containing some PII was compromised. This is a final warning to reach out by 4 August 2026 before HookPhish leak along with several annoying (digital) problems that'll come your way. Make the right decision, don't be the next headline. | | Date of Breach | Aug 1, 2026, 00:00 UTC | | Discovery Date | Aug 2, 2026, 00:00 UTC | | Region | CH | | Target Domain | alcon.com | | Business Sector | Healthcare | How to reduce your ransomware risk. Most ransomware intrusions start with a stolen password or a phishing email. A few proactive steps sharply cut your exposure: * real-time breach alerts - close the gap attackers exploit. * phishing simulations - close the gap attackers exploit. Disclaimer. HookPhish does not engage in the exfiltration, downloading, taking, hosting, viewing, reposting, or disclosure of any stolen information. All breach data reported here is sourced from publicly available threat intelligence feeds for awareness purposes only.